APOE and Alzheimer disease: The apoE4-271 fragment has been proposed to be present in the brain of AD patients, to induce neurofibrillary tangle-like intracellular inclusions in cultured neurons, to clear inefficiently Aβ peptides and to elicit AD-like neurodegeneration and behavioral deficits in transgenic mice14, 15, 31.